Teledactyl (TDCL)

Blockchain for Healthcare

Review Score
2.73/5
ICO Price
0.00057 BTC
Pre ICO Price
0.00057 BTC
Soft Cap
10,000,000 USD
Hard Cap
25,000,000 USD
Pre ICO Start Date
3 July 2018
Pre ICO End Date
10 August 2018
Start Date
11 August 2018
End Date
18 September 2018

What is Teledactyl?

 

Teledactyl is being developed as an original Personal Health Record (PHR) Blockchain system for the healthcare industry that has the ability to store and share patient information—like a patient’s health record—digitally through the most secured encrypted transmission platform known today.

In addition, it will offer cryptocurrency utility tokens used by those who do or do not have third-party insurance in exchange for health services. Teledactyl is a total solution for the new generation of healthcare.

Open Website Open Whitepaper

Rating

Average Rating 54.50%
ICO Bench 48%
ICO Marks 61%

General Info

Symbol TDCL
Category Health
Pre ICO Start Date 3 July 2018
Pre ICO End Date 10 August 2018
Start Date 11 August 2018
End Date 18 September 2018
Bonus Available
Bounty Not Available
Platform Waves
Accepting BTC
Country USA
Whitelist/KYC Whitelist

Investment Info

PreICO Price 1 TDCL = 0.00057 BTC
ICO Price 1 TDCL = 0.00057 BTC
Bonus

20% Pre-Sale

10% Public Sale
Tokens for sale 1000000000

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.